Reports of the unprecedented occurrence of Kaposi's sarcoma and fatal Pneumocystis carinii pneumonia in previously healthy homosexual men in New York and California in 198 1 heralded the onset of the current human epidemic known as the acquired immunodeficiency syndrome
Since those initial reports, the incidence and spread of this disease have increased dramatically. Individuals affected with AIDS develop a prodrome of generalized lymphadenopathy, referred to as lymphadenopathy syndrome, frequently culminating in a selective and profound depression of cellmediated immunity that thus far appears irreversible. Typically, this immunodeficiency is characterized by a reversal of the ratio of T4 + (helper-inducer) to T8 + (suppressor-cytotoxic) subsets of lymphocytes in the peripheral circulation, impairment of delayed cutaneous hypersensitivity and decreased responsiveness of T-lymphocytes to in vitro mitogen stimulation. Patients with AIDS frequently develop life-threatening infections with one or more of the following opportunistic pathogens: Pneumocystis carinii, Cryptococcus neoformans, Toxoplasma gondii, Candida albicans, Mycobacterium tuberculosis, Mycobacterium aviumintracellulare, cytomegalovirus (CMV), Herpesvirus hominis (simplex), adenoviruses and papovaviruses.
In addition, Kaposi's sarcoma and Burkitt's-like lymphoma occur with much greater frequency in AIDS patients than in the general population.
Although initially confined to certain high-risk groups that included promiscuous male homosexuals, intravenous drug-abusers, Haitians, hemophiliacs, and blood transfusion receipients, AIDS is being increasingly recognized in patients that do not belong to any of these groups. It is now well established that the disease can be transmitted through both homosexual and heterosexual contact through use of contaminated hypodermic needles and blood products, and from infected mothers to their newborn children. Early epidemiologic evidence strongly suggested that AIDS was caused by a transmissible agent. In 1983, a retrovirus variously termed lymphadenopathy-associated virus (LAV), human T-lymphotropic virus type I11 (HTLV-111) or AIDS-associated retrovirus (ARV) was isolated and shown to be the cause of AIDS.2, 39, 45 This agent will be referred to as HTLV-III/LAV in this review. Interestingly, HTLV-III/LAV has been shown to have a number of biological characteristics in common with several viruses of ungulates classified in the lentivirus subfamily of r e t r o v i r u s e~.~~~~~ These agents include maedi-visna virus (MVV), caprine arthritis-encephalitis virus (CAEV) and equine infectious anemia virus (EIAV). Recently, HTLV-III/LAV has been shown to be neuropathic and associated with dementia and a characteristic granulomatous encephalitis in adult as well as pediatric patients. 14,28,47-49
By the fall of 1985, the Centers for Disease Control had received reports of more than 15,000 cases of AIDS in the United States, more than half of these reported during the preceding 12 months.'O Using an HTLV-III/LAV infection-to-AIDS ratio of between 50 : 1 and 100 : 1, it has been estimated that by the end of 198 5 somewhere between 1 and 2 million Americans had already been infected with HTLV-III/LAV. Conservative estimates project that between 1 to 2% of those individuals infected with HTLV-III/LAV will develop AIDS every year and of these at least 75% will die of complications related to their disease. Although most of the early reports of AIDS were from the United States and Western Europe, the disease has now been recognized on six of the seven continents of the world, and is a problem of global concern.
Control of this new human epidemic will require two major medical achievements, both of which present formidable challenges. The first of these will be the development of innovative and probably unique forms of antiviral therapy that ideally will eliminate the retrovirus, HTLV-III/LAV, from persistently infected patients. There is no precedent for a drug of this kind in all of medicine. The second will be the development of an effective vaccine against a virus belonging to a subfamily of retroviruses, i.e., lentiviruses, noted for their facility to undergo extensive antigenic mutation in persistently infected hosts. A reproducible animal model for AIDS would great-ly facilitate the development of control measures, and a wide variety of animal species have been inoculated with HTLV-IIULAV. To date, the only species found to be susceptible to HTLV-III/LAV and to demonstrate persistent viremia following experimental infection is the chimpanzee, Pan troglodytes. 1,5~17- 19 However, after more than two years of clinical observation, experimentally infected chimpanzees have yet to manifest more than a transient lymphadenopathy, and none of them have died of a disease comparable to AIDS. Because of these limitations and the fact that the chimpanzee is endangered and in extremely short supply, this species will probably be of limited value to AIDS research. Attempts to infect other species of nonhuman primates including those of the genus Macaca with HTLV-III/LAV, have been uniformly unsuccessful. Macaques in captivity have been shown to spontaneously develop several syndromes with overlapping clinical and pathologic manifestations common with AIDS. Unfortunately, the literature on these naturally occurring models of AIDS has been conflicting and understandably subject to some controversy and misunderstanding. In this review I summarize the current knowledge regarding several naturally occurring and experimentally induced immunodeficiency syndromes of nonhuman primates and indicate the similarities and dissimilarities of each to AIDS.
Since the early 1970's, veterinary pathologists at several Regional Primate Research Centers in the United States have noted sporadic occurrences or outbreaks of unusual opportunistic infections or neoplasms in their colonies of macaque monkeys. In most instances, these diseases were of the type commonly associated with profound immunosuppression. They included: avian tuberculosis, progressive multifocal leukoencephalopathy, retroperitoneal fibromatosis and spontaneously occurring lymphomas.21~25~30~50~5z~54 After the original descriptions of AIDS in man, it became apparent that there were many clinical and pathological parallels between this new human epidemic and the poorly understood syndromes that had been endemic in several colonies of macaque monkeys in the United States for at least 10 years.
In 1983, investigators at the New England and California Primate Research Centers independently described the clinical and pathological features of the AIDS-like syndrome of macaque monkeys as it occurred in representative cohorts of affected animals in their respective c 0 1 0 n i e s .~~~~~ In both reports references were made to lesions found in other.animals presumed to have been affected with the same syndrome but which were not included in the cohorts because no hematologic or immunologic data were available on them. In fact, the report from the California Center referred to five separate outbreaks occurring over a 14
year period. There were many similarities between the outbreaks described at these two Centers; there were also subtle differences, the importance of which is just beginning to emerge. At both Centers the disease occurred primarily in animals less than 3 years of age housed in outdoor gang cages or corrals. At New England, the disease principally affected Macaca cyclopis and M. mulatta and to a lesser extent M. fascicularis, whereas at California primarily M. mulatta and M. arctoides were involved. The California Center does not have M. cyclopis, but the New England Center has a small colony of M. arctoides which thus far have remained unaffected by the AIDS-like disease. At both Centers the disease began with a prodrome of generalized lymphadenopathy and splenomegaly followed by intractable diarrhea and profound weight loss. Recurrent, non-vesicular rash was also noted at the New England Center during the early stages of the disease.
The laboratory findings in affected animals were similar at both Centers and included: anemia, neutropenia, lymphopenia, variable thrombocytopenia and monocytosis, hypogammaglobulinemia, and a reduced blastogenic responsiveness of T lymphocytes to in vitro lectin stimulation. At the New England Center affected animals tended to have a reduced T4/T, ratio.
At both Centers affected animals generally died with one or more opportunistic infections and/or neoplasia. The opportunistic infections common to both Centers included: generalized cytomegalovirus (CMV), Mycobacterium avium-intracellulare infection, cryptosporidiosis, intestinal trichomoniasis, oro-esophageal candidiasis and noma (ulcerative gingivitis). Other opportunistic infections detected in animals that died at New England but, to date, not at California included: Pneumocystis carinii pneumonia, SV-40 pneumonia and nephritis and hematogenous Hexamita infection.34%38 Progressive multifocal leukoencephalopathy has been observed only in M. arctoides at the California Center.25 Interestingly, and probably of significance, animals involved in the two most recent outbreaks at the California Center reportedly developed a high incidence of bacterial infections of many types, a feature that has not been observed in the immunodeficient animals at the New England Center.*' These included infections by organisms that traditionally are not thought of as typical opportunistic pathogens; Campylobacter, Shigella, Klebsiella, Staphylococcus, Streptococcus, Yersinia, Pseudomonas, and Escherichia.
The lymph nodes of affected animals at both Centers undergo rather striking changes during the course of the disease. In the early lymphadenopathy stages, the enlarged nodes exhibit marked follicular hyperplasia, which subsides as the disease progresses so that terminally the same nodes are markedly depleted of fol- Furthermore, a high percentage of the animals with lymphoma at the New England Center were shown to have antibodies that react with the human T cell leukemia virus type I (HTLV-I) infected cells, suggesting that a related retrovirus may be the cause of the simian lymphoma^.^^ A lymphoproliferative disorder that does not fit the usual criteria for lymphoma has also been observed in macaque monkeys with the immunode-ficiency syndrome at the New England Center.34 Cutaneous fibrosarcomas have been described in several M. mulatta affected during the most recent outbreak of immunodeficiency syndrome at the California Center but have not been observed at the New England Center. 27 The immunodeficiency diseases of macaque monkeys at both the New England and California Centers were subsequently shown to be transmissible with whole blood, plasma, frozen serum and tissue homogenates from animals with l y m p h~m a .~~.~~.~~ These findings led to an intensive search for an etiologic virus and in February 1984 investigators at the New England Center and those at the California Center working with investigators at the National Institutes of Health (NIH) independently reported the isolation of a type D retrovirus from macaque monkeys with the spontaneously occumng immunodeficiency syndrome.1'.23 The viruses were found to be closely related to Mason-Pfizer Monkey Virus (MPMV), a retrovirus previously isolated from but probably not responsible for, a mammary carcinoma of a M. mulatta. l3 The fact that inoculation of MPMV had previously been shown 8 years earlier to cause a disease with marked similarity to the naturally occurring immunodeficiency syndrome in 41 of 68 newborn M. mulatta made these new type D isolates strong candidates for the etiologic agents of the macaque immunodeficiency syndrome.15 In fact, investigators from the NIH and California concluded in their initial report that they had transmitted simian AIDS based upon the death oftwo 17.5-month-old M. mulatta 8 weeks after inoculation with the type D/California isolate. 23 These authors stated that both animals died of a pneumonia probably caused by an opportunistic virus because neither had responded to antibiotic therapy. However, the virus putatively causing the pneumonia was not isolated, nor was the type of pneumonia described histopathologically. Investigators from the New England Center, on the other hand, stated in their original report that the relationship of their new type D retrovirus isolate, i.e., type D/New England, to the macaque immunodeficiency syndrome was not yet known, but since, at that time, it had only been isolated from clinically ill animals the virus could be either the etiologic agent of the syndrome or possibly another opportunistic pathogen. l 2 The New England investigators reported that experimental inoculation of the type D/New England isolate into 11 one-day to 12 month-old M. mulatta failed to induce a disease analogous to that which occurred naturally at their Center. 35 The virus did, however, induce transient lymphadenopathy, neutropenia and decreased blastogenic responsiveness of peripheral blood lymphocytes (PBL), all of which returned to normal during the 13 month study period. Two of the experimental animals which were less than 4 months of age at inoculation died during the study, one of aspiration pneumonia (from bottle feeding) the other of an undetermined cause. Both had marked thymic atrophy and secondary depletion of lymphocytes in their spleens and lymph nodes, a finding that had been reportedly previously in MPMV inoculated infant monkeys. However, neither had microscopic evidence of an opportunistic infection or neoplasia. It was thus concluded that though type D/New England, like MPMV, did cause thymic atrophy with associated depletion of lymphocytes in young macaque monkeys since these lesions did not appear to predispose these animals to the usual opportunistic infection associated with immunosuppression, the disease was not analogous to the AIDS-like disease which was endemic at that Center. The nine surviving animals remained clinically healthy more than 2 years after inoculation of the virus, a finding that also was inconsistent with the results of their earlier transmission studies in which blood, serum and lymphoma tissue homogenates from naturally occumng cases resulted in 100°/o mortality when inoculated into healthy animals. In the mean-time, the type D/New England and type DKalifornia isolates were shown by restriction enzyme mapping to be closely related. 41 Expanded transmission studies by the California group with DKalifornia indicated that four of nine M. mulatta inoculated with that virus died within 2-3 months of inoculation with evidence of CMV infection, noma, Klebsiella pneumoniae and Streptococcus canis ~epticemia.~~ During the 27 week study period four of the remaining five developed persistent lymphadenopathy, anemia, neutropenia and persistent decreased blastogenic responsiveness of PBL, all clinical features of the last two outbreaks of naturally occumng disease at that Center. The fifth animal developed the same, but transient abnormalities.
Type D retroviruses have subsequently been isolated at the Washington and Oregon Primate Centers from rhesus monkeys (M. mulatta), pig-tailed macaques (M. nemestrina), and Celebes black macaques (M. nigra) also having an immunodeficiency s y n d r~m e .~~,~~ At those Centers the dominant clinical manifestation of the syndrome is a peculiar proliferation of fibrovascular connective tissue of the retroperitoneum. This lesion, referred to as retroperitoneal fibromatosis (RF), is transmissible and occurs in both localized or progressive forms.2o In some animals the fibromatous lesions are confined to the subcutis and appear identical to the fibrosarcomas described in two of 29 immunodeficient macaques involved in the last outbreak at the California
The abdominal form of RF has been observed occasionally in animals with the naturally occurring and experimentally transmitted simian immunodeficiency syndromes at the New England Center, but has not been seen at the California Center. 34 On the other hand, the subcutaneous form of RF and fibrosarcomas have not been observed in the more than 100 cases of natural or experimentally induced immunodeficiency syndrome studied at the New England Center. Recent data indicate that the type D/Washington and type D/Oregon isolates are more closely related to one another than they are to the New England and California isolates and therefore should probably be considered a different s e r~t y p e .~~ Accordingly, it has been proposed that the California and New England type D isolates be referred to as SRV-1 (SAIDS retrovirus type 1) and the Washington and Oregon isolates be designated SRV-2. SRV-2 specific gene sequences have been demonstrated in RF tissue from Celebes black macaques and pig-tailed macaques at the Oregon and Washington Centers respectively, strongly suggesting an etiologic role for this None of the type D isolates have any genomic or antigenic relationship to HTLV-III/LAV, the cause of human AIDS. 46 Because of the inconclusive results of the transmis-sion studies with their type D isolate, investigators at the New England Center renewed their efforts to isolate other viral agents that could be the cause of the naturally occurring immunodeficiency disease in their colony. This search was prompted, in part, by the fact that in July 1983 a retrovirus having the characteristic morphology of a lentivirus was observed electron microscopically in the lymph nodes of two juvenile M. mulatta that had died 3 months after being inoculated with serum from an animal that died 15 months earlier with generalized CMV infection. The donor of the serum used for inoculation was one of 13 animals, all of whom died of an experimentally transmitted macaque immunodeficiency syndrome after inoculation with tissue homogenates and blood from an M. mulatta with experimentally transmitted lymphoma as described p r e v i o~s l y .~~ The two animals in which the lentivirus particles were observed died of extensive cryptosporidiosis, oro-esophageal candidiasis and an unusual multifocal granulomatous encephalitis. The significance of the brain lesions in these monkeys will become apparent from information presented later in this review. The morphology of the newly recognized lentivirus particles had some similarity to that of mature type D particles studied earlier in that the extracellular particles had cylindrical nucleoids; however, their mode of nucleocapsid and envelope assembly was different from that of type D agents and more closely resembled that described for type C retroviruses, particularly the lentiviru~es.~ Furthermore, the morphology of the retroviral particles observed in these two young macaques, in addition to resembling that of the known ungulate lentiviruses, EIAV, M W and CAEV, also was identical to that described two months earlier (May 1983) for a retrovirus isolated from a human patient with lymphadenopathy syndrome by investigators at the Pasteur Institute in Paris, France.2 This report was the first description of the virus now known as lymphadenopathy-associated virus (LAV), a virus almost identical to HTLV-111.
Numerous attempts to isolate the lentivirus-like agent from tissues and sera of these and other affected macaques failed until samples were inoculated onto or cocultivated with human PBL maintained with Interleukin-2 (IL-2) or specific established cell lines of transformed human T lymphocytes (H-9 or HUT-78 cells). The latter techniques were those used by investigators at the National Cancer Institute to obtain the first isolates of HTLV-III/LAV from AIDS patients in the United States.45 The use of these highly permissive, human cell lines led to the isolation and characterization of the retrovirus that had previously been seen in lymph nodes of the two macaques with serum-trans-mitted immunodeficiency syndrome and subsequently from animals with experimentally-transmitted lymphoma and naturally occurring lymphoproliferative disease at the New England Center.8J2
Characterization of this new simian retrovirus revealed that it had many features in common with HTLV-III/LAV, thus it has been named STLV-I11 (simian T-lymphotropic virus type 111). There already exists a simian counterpart of the transforming human T-lymphotropic virus type I (HTLV-I), termed simian T-lymphotropic virus type I or STLV-I. 42, 55 The features that STLV-I11 have in common with HTLV-III/ LAV are: 1) the mechanism of viral assembly and morphologic appearance of mature particles are identical; 2) both are trophic for the T4+ subset of T lymphocytes; 3) both produce large, multinucleate, syncytial cells in H-9, Hut-78 and human PBL's maintained in IL-2; 4) both have reverse transcriptases that prefer Mg++ as their divalent cation; 5 ) both are released in abundance into the culture medium of permissive cells and thus can be transferred by supernatants in vitro and by cell-free serum or plasma in vivo; 6) radioimmunoprecipitation analysis of STLV-I11 infected cells, using monoclonal antibodies and sera from patients who are seropositive for HTLV-III/LAV has revealed cross-reactive specific proteins of 160 daltons, 120 daltons, 5 5 daltons, and 24 daltons, all similar in size to the major gag and env proteins encoded by HTLV-IIULAV; and finally 7) both are neuropathic and have been associated with a multifocal granulomatous encephalitis. 12,32,33,36,47,48 Preliminary data using hybridization techniques at low stringency indicate there is probably less than 75% genome homology between HTLV-III/LAV and STLV-111, but since the simian virus has not yet been molecularly cloned or sequenced detailed genomic comparisons have not been made (R. C. Desrosiers, personal communication).
After isolating STLV-I11 from three different animalstwo with experimentally transmitted immunodeficiency syndrome and one with experimentally transmitted lymphoma-two overriding questions emerged. First, was this agent pathogenic for M. mulatta and, if so, was the disease it produced comparable to the naturally occurring immunodeficiency syndrome? Secondly, did concurrent infection with type D/New England in any way alter the course or character of the disease produced by STLV-III? To answer these questions, investigators at the New England Center inoculated six M. mulatta with STLV-III.36 Four of these were healthy, 6-month-old animals from which type D/New England and STLV-I11 could not be cultured prior to study, the other two were clinically healthy, except for mild axillary and inguinal lymphadenopathy, 18-month-old animals who had been in-oculated approximately 12 months earlier with type D/New England as part of the original 11 macaques previously described. 35 STLV-I11 could not be isolated from the latter two animals prior to their being inoculated with it. Inoculation was by the intravenous route in all six animals and consisted of STLV-I11 grown in normal human PBL maintained in IL-2. These same cells were shown to be free of exogenous retroviruses as determined by lack of reverse transcriptase activity prior to inoculation with samples containing the simian virus.
The clinical, immunologic, and histopathologic findings on four of the five animals that died between 127 and 160 days post-inoculation have been published. 36 The fifth animal died at 350 days post-inoculation and one remains alive and clinically healthy more than 14 months post-inoculation, despite continued isolation of STLV-I11 from monthly blood samples. All five animals that died developed a rash and diarrhea within 4-6 weeks following inoculation and Trichomonas was demonstrable in their stools. During the course of their disease there was also moderate to severe (15-60°/o) weight loss; a reduction in the number of T4-t lymphocytes in the peripheral circulation which became elevated during the last few weeks of life; a persistent diminished blastogenic response of PBL to pokeweed mitogen (PWM), but inconsistent response to concanavalin A (Con A) and xenogeneic stimulator cells; and, surprisingly, no consistent hematologic abnormalities.
The gross and microscopic findings at necropsy revealed that all five animals had atrophic thymuses and mild to moderate depletion of lymphocytes from follicular and paracortical areas of lymph nodes; four of the five had a striking multifocal granulomatous encephalitis with syncytial giant cell formation, a lesion seen previously only in the two serum inoculated animals from which STLV-I11 was subsequently isolated; three of the five had extensive necrotizing adenoviral pancreatitis; one of these also had an adenoviral pneumonia and cholangitis; and the last animal to die had extensive intestinal cryptosporidiosis, but no evidence of adenoviral infection or encephalitis. Subsequent electron microscopic examination of the brain lesions in the four animals inoculated with STLV-I11 and the two animals that developed identical lesions after being inoculated with frozen serum revealed numerous lentiviral particles, consistent with STLV-111, within macrophages, histiocytes and syncitial giant cells comprising the lesions.36 Thus, STLV-111, like HTLV-III/LAV is capable of inducing a very characteristic primary retroviral encephalitis. This retrovirus-induced encephalitis in monkeys and in man is reminiscent of, but considerably less demyelinating than, that which occur in sheep with MVV infection or goats with CAEV infection. There was no significant difference in the course or nature of the disease between those animals infected with type Dmew England and STLV-111 and those infected with STLV-I11 alone.
Recently, there have been reports of the isolation of STLV-III-like viruses from African green monkeys, Cercopithecus aethiops and from sooty mangabey monkeys, Cercocebus atys, both native to To date there have been no published reports on experimental studies of the pathogenicity of these agents in their natural hosts. These reports along with limited serologic data from human populations in Africa have led some investigators to speculate that HTLV-1111 LAV has its origin from that continent and probably represents a simian virus which has undergone genetic mutation through serial passage in human beings. However, confirmation of this will require comparisons of the nucleic acid sequences of human and simian AIDS viruses to determine the degree of relatedness. This has not yet been done.
HTLV-I related simian viruses, i.e., STLV-I, may be involved in the pathogenesis of lymphomas and lymphoproliferative disorders seen in macaque monkeys with the simian acquired immunodeficiency syndrome. Serologic surveys have indicated a high frequency of STLV-I infection among wild caught macaque monkeys. 26 The STLV-I isolates from such monkeys have been shown to have a remarkable degree of genetic relatedness, i.e., greater than 90% genomic homology, to HTLV-I. Eleven of 13 macaques with lymphoma or lymphoproliferative disorders, but only seven of 95 healthy macaques in the New England colony, had serum antibodies to membrane antigens of HTLV-I infected cells.29 While these findings suggest that an HTLV-I-like virus should be the cause of lymphoma and lymphoproliferative disorders of these animals, this has not been substantiated in subsequent studies in which DNA from ten macaque lymphomas, some from animals who were seropositive to HTLV-I, failed to hybridize with an HTLV-I probe (R. C. Desrosiers, personal communication). These disparate findings, thus far, remain unexplained.
It now appears that the original descriptions of naturally occurring outbreaks of an acquired immunodeficiency syndrome of macaque monkeys at the New England and California Primate Research Centers in all likelihood included animals infected with two different retroviruses, i.e., a type D retrovirus and an HTLV-III/LAV-related lentivirus now referred to as STLV-III. 27, 37 The clinical and pathological findings in animals naturally and experimentally infected with these two distinctive agents and their effects on the host's immune system were sufficiently overlapping that the syndromes resulting from them were initially regarded as one. The marked predisposition of animals in the more recent outbreaks in the California colony to bacterial infections, in contrast to their earlier experience where most animals succumbed to lymphomas, avian tuberculosis and progressive multifocal leukoencephalopathy was perhaps the single most important clue that they may have been dealing with two different agents resulting in clinical immunosuppression. The type D retrovirus isolates are noted for their ability to cause profound neutropenia, in addition to their destructive effect on the thymus and secondary lymphoid organs of young animals in particular. It is probably this property that accounted for the overwhelming members of bacterial infections seen in the more recent outbreaks in California. Moreover, it is likely that the animals with noma and retroperitoneal fibromatosis described in the initial report from the New England Center may have been infected with the type D retrovirus. Recently developed ELISA tests for type D retroviruses, STLV-I and STLV-111 will now permit large scale retrospective and prospective screening of primate colonies for infection with these three agents and should yield important new information regarding their respective roles in the pathogenesis of these spontaneously occurring simian immunodeficiency syndromes.
Both the type D retrovirus and STLV-111-induced immunodeficiency syndromes of macaque monkeys provide excellent model systems with which to explore the cellular and molecular basis of retrovirus-induced immunodeficiency in species that are phylogenetically closely related to man. The STLV-111 model system, because of the antigenic relatedness of this virus to HTLV-III/LAV would appear, at present, to be the more appropriate for use in studies in which new strategies of antiviral therapy and vaccine development are explored to control and/or abolish the current epidemic of AIDS.
